Jeff Yass’s AEON Biopharma AEON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.3K Buy
+21,018
New +$6.5K ﹤0.01% 13271
2023
Q1
– Sell
-859
Closed -$621K – 12468
2022
Q4
$621K Buy
859
+150
+21% +$107K ﹤0.01% 7307
2022
Q3
$503K Buy
+709
New +$502K ﹤0.01% 8469

Other funds holding AEON

Jeff Yass's AEON Position: Q3 2026 in Review

Jeff Yass opened a new position in AEON Biopharma (AEON) in Q3 2026: 21,018 shares worth $6.3K. The stake represents ﹤0.01% of the portfolio and ranks #13271 among its holdings. This is a return to the name: Jeff Yass previously reported a position in AEON as recently as Q4 2022.

Jeff Yass first reported a position in AEON in Q3 2022 and has held it in 3 quarters since. The position peaked at $621K in Q4 2022. 28 funds tracked by Wall St. Rank hold AEON as of Q3 2026.

  • Jeff Yass held 21,018 shares of AEON Biopharma worth $6.3K as of Q3 2026.
  • AEON Biopharma was a new Jeff Yass position in Q3 2026.
  • AEON Biopharma made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #13271 holding.
  • Jeff Yass first reported a position in AEON Biopharma in Q3 2022 and has held it in 3 quarters since.
  • Jeff Yass's AEON Biopharma position peaked at $621K in Q4 2022.
  • 28 funds tracked by Wall St. Rank held AEON Biopharma as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.